GPCR
Structure Therapeutics Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -9.2% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 65 | 0 | 29.18M | $1.56B | +7 | −8 |
| Q1 2026 | 68 | -4 | 35.35M | $1.72B | +6 | −10 |
| Q4 2025 | 71 | 0 | 34.16M | $2.38B | +1 | −1 |
| Q3 2025 | 15 | 0 | 15.29M | $428.25M | +1 | −1 |
| Q2 2025 | 12 | 0 | 15.65M | $324.65M | n/a | n/a |
| Q1 2025 | 10 | +2 | 10.69M | $185.13M | +2 | n/a |
| Q4 2024 | 8 | -1 | 12.53M | $339.72M | n/a | −1 |
| Q3 2024 | 8 | -3 | 13.88M | $609.35M | n/a | −3 |
| Q2 2024 | 11 | n/a | 14.51M | $569.72M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 5.69M | -17.3% | $159.30M | 0.0% | ▼ Trim | 6 | SEC ↗ ×6 |
| 2 | Fidelity (FMR) ✦ | 5.25M | +6.8% | $147.01M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 3 | Millennium Management ✦ | 1.27M | +4.5% | $35.69M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 577.74K | n/a | $16.18M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 5 | Goldman Sachs Group ✦ | 504.40K | n/a | $14.12M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 443.80K | -66.6% | $12.43M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Point72 Asset Management ✦ | 407.70K | +23.6% | $11.42M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 289.39K | -18.0% | $8.10M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 263.94K | +8.5% | $7.39M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 10 | Two Sigma Investments ✦ | 182.91K | Nieuw | $5.12M | 0.0% | New | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 153.90K | +37.5% | $4.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 116.30K | n/a | $3.26M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 13 | Geode Capital Management ✦ (passief) | 57.96K | +7.0% | $1.62M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (passief) | 46.02K | +37.5% | $1.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 36.35K | +198.8% | $1.02M | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Two Sigma Investments | $5.12M | 0.0% |
Verlaten
| Marshall Wace | $3.65M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 118.22K aandelen, $5.19M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.